HomeResearch GuideThird-Party Testing: Ensuring Research Integrity
Back to Research GuideQuality Assurance

Third-Party Testing: Ensuring Research Integrity

Northbridge Research LabsFebruary 15, 2026 · Updated September 23, 20266 min read
Quality AssuranceTestingThird-PartyVerificationISO 17025Reproducibility

Why independent laboratory testing matters for research compounds, what the common methods show, where in-house testing creates conflicts of interest, what ISO/IEC 17025 accreditation actually means, and how to verify a testing lab yourself.

An experiment is only as reliable as the materials that go into it. If a peptide is not what its label says, or is present at a different purity or amount, every result built on it inherits that error, and nothing in the data will announce the problem. Independent testing is how a researcher gets evidence about a compound from someone other than the party selling it. This guide explains why that independence matters, what the tests measure, what accreditation does and does not guarantee, and how to check a testing laboratory for yourself.

Why Verification Matters

Irreproducibility is an expensive, well-documented problem in life science. An economic analysis of preclinical research estimated that the cumulative prevalence of irreproducible studies exceeds 50%, corresponding to roughly $28 billion a year in the United States alone [1]. The authors grouped the causes into four categories, one of which is biological reagents and reference materials, and identified reagents as one of the two areas where improvement would pay off most [1].

For peptides specifically, a label claim is not evidence of what is in the vial. A 2024 study made test purchases of semaglutide sold without a prescription by illegal online pharmacies and analyzed the vials that arrived. Measured semaglutide purity ranged from 7.7% to 14.37%, against the 99% printed on the product labels; the measured semaglutide content exceeded the labeled amount by 28.56% to 38.69%; and endotoxin was detected in every sample, although no viable microorganisms were found [4]. Each of those vials carried a label; only analysis revealed the gap, and it also showed that purity and quantity are separate questions that can each be wrong in a different direction.

The Problem With Testing Your Own Product

In-house testing is not worthless. Manufacturers need their own analytical labs for process control, and many are competent. The difficulty is structural: when the party that profits from a passing result also produces the result, there is an incentive to choose favorable methods, retest until a sample passes, or report only the good lots, and an outside reader has no way to tell whether any of that happened.

Clinical research offers a measured example of how sponsorship shapes outcomes. A systematic review of 30 studies found that research sponsored by pharmaceutical companies was more likely to report outcomes favoring the sponsor than research with other funding, with an odds ratio of 4.05, even though the industry-funded studies were not found to be of poorer methodological quality [2]. The explanations the authors offered included choice of comparator and publication bias, which are decisions about what to test and what to show rather than errors in the measurements themselves [2]. The same incentive applies to a seller testing its own compounds, which is why independent testing, and publishing the results whatever they are, carries more weight.

Independence also has limits worth understanding. The seller usually pays the outside lab, and the lab tests the sample it receives. Independence is strongest when the lab has no ownership ties to the seller, the report names the lab and can be traced back to it, the sample is linked to a specific production lot, and results are published for lots whether or not they flatter the product.

What the Tests Measure

Pharmacopoeial specifications for peptide drugs are built around three core questions: identification, purity, and assay (how much of the compound is present) [5]. Research-grade peptides have no official monographs, and a comparison of the European and United States pharmacopoeias found their peptide specifications were not well harmonized even for approved drugs [5], so for research materials it is up to the buyer to see which of these questions a given report actually answers.

  • Identity: mass spectrometry measures molecular mass, which should match the value calculated from the sequence and any modifications.
  • Purity: reversed-phase HPLC separates the target peptide from related impurities such as truncated or deletion sequences; purity is the main peak's share of total peak area.
  • Quantity or net content: how much peptide is actually in the vial, which purity alone does not tell you, since counter-ions and residual moisture also contribute to the weight of the powder.
  • Endotoxin: the Limulus amebocyte lysate (LAL) test uses a clotting cascade from horseshoe crab blood cells that is triggered by bacterial lipopolysaccharide, making it a very sensitive assay for endotoxin contamination [6]. Endotoxin matters in cell and animal work because it provokes inflammatory responses that can be mistaken for an effect of the peptide.
  • Sterility: incubation in growth media to detect viable bacteria or fungi, relevant mainly for solutions used in cell culture or in vivo models.

Our companion guide on reading a peptide certificate of analysis walks through each of these fields in detail.

What ISO/IEC 17025 Accreditation Means

ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. It covers both how the laboratory is managed and how it does technical work, and it requires the lab to operate impartially. An accredited laboratory has been assessed by an independent accreditation body against that standard for a defined list of tests, known as its scope of accreditation.

One laboratory's account of implementing the standard gives a sense of what it involves in practice: formal staff training plans and records, documented method development and validation, estimation of measurement uncertainty, a defined calibration and maintenance program for equipment, document control, corrective and preventive action procedures, internal audits, and regular review of proficiency testing results [3]. Proficiency testing is especially useful to an outside reader, since it means the lab periodically analyzes samples of unknown value and is compared against other labs.

  • Accreditation is test-specific. A lab accredited for one method is not automatically accredited for others, so check that the relevant method, such as HPLC purity or endotoxin testing, is on its scope.
  • ISO 9001 certification is a different thing. It covers general quality management and says nothing about analytical competence.
  • Good Laboratory Practice (GLP) is a regulatory framework for nonclinical safety studies submitted to regulators, not a general quality badge for analytical testing.
  • Accreditation shows that a lab has competent systems. It does not by itself prove that any single report is authentic or that it describes the vial in your hand.

How to Verify a Testing Lab

  • Identify the lab: a real report names the laboratory, gives a physical address, and carries a unique report or sample number.
  • Check accreditation at the source: accreditation bodies publish directories of accredited labs and their scopes. Look the lab up there rather than relying on a logo on the report.
  • Confirm the report with the lab: many labs will confirm whether a report number is genuine, and some provide online verification.
  • Match the lot: the lot or batch number on the report should match the lot printed on your vial.
  • Check the dates: the test date should come after the lot was manufactured and before it was sold.
  • Look for the underlying data: a chromatogram and mass spectrum, not only a purity number, show that the analysis was actually run on this material.

Red flags

  • No named laboratory, or a lab that cannot be found independently
  • No lot number, or one certificate reused across many lots or sizes
  • Identical purity values across unrelated products and batches
  • Edited or inconsistent details, such as a different compound or quantity in the chromatogram header than in the report body
  • Reluctance to share the original report or to let you contact the lab

How Northbridge Research Labs Approaches Testing

Every Northbridge Research Labs batch is independently tested by a third-party laboratory. Certificates are published by lot in our COA library at /coa, where you can look up the lot number printed on your vial. Products do not ship with a printed certificate; the online library is the record. If you cannot find the lot you are looking for, contact our support team. We encourage researchers to apply the checks above to our certificates just as they would to anyone else's.

Note: Northbridge Research Labs supplies compounds for laboratory research use only. They are not for human or veterinary use. Independent testing documents the identity and quality of research materials; it does not make them suitable for any use outside the laboratory.

Key Research References

  1. Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biology. 2015;13:e1002165. doi:10.1371/journal.pbio.1002165
  2. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-1170. doi:10.1136/bmj.326.7400.1167
  3. Honsa JD, McIntyre DA. ISO 17025: practical benefits of implementing a quality system. Journal of AOAC International. 2003;86:1038-1044.
  4. Ashraf AR, Mackey TK, Vida RG, et al. Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription: market surveillance, content analysis, and product purchase evaluation study. Journal of Medical Internet Research. 2024;26:e65440. doi:10.2196/65440
  5. Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. Journal of Peptide Science. 2009;15:697-710. doi:10.1002/psc.1167
  6. Iwanaga S. Biochemical principle of Limulus test for detecting bacterial endotoxins. Proceedings of the Japan Academy, Series B, Physical and Biological Sciences. 2007;83:110-119. doi:10.2183/pjab.83.110
Share this article:

Research Use Only: The information in this article is for educational and research purposes only. All products mentioned are intended for laboratory research use only and are not approved for human or veterinary use.